(HPQ) HP - Ratings and Ratios
Laptops, Desktops, Printers, 3D Printers, Workstations
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.10% |
| Yield on Cost 5y | 5.74% |
| Yield CAGR 5y | 10.32% |
| Payout Consistency | 90.3% |
| Payout Ratio | 37.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 30.8% |
| Value at Risk 5%th | 47.8% |
| Relative Tail Risk | -5.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.80 |
| Alpha | -46.19 |
| CAGR/Max DD | -0.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.504 |
| Beta | 1.188 |
| Beta Downside | 1.439 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.29% |
| Mean DD | 14.87% |
| Median DD | 11.57% |
Description: HPQ HP December 17, 2025
HP Inc. (NYSE: HPQ) delivers personal computing, printing, 3D printing, hybrid-work, gaming and related technologies worldwide through three operating segments: Personal Systems (desktops, notebooks, workstations, thin clients, POS systems, displays, software and services), Printing (consumer and commercial printers, supplies, graphics, 3D-printing and personalization solutions) and Corporate Investments (business incubation and venture projects). The company, originally founded as Hewlett-Packard in 1939 and re-branded in 2015, serves consumers, SMBs and large enterprises from its Palo Alto headquarters.
Key recent metrics: FY 2024 Q2 revenue was $16.5 billion, with the Personal Systems segment contributing ~55 % and the Printing segment ~30 % of total sales; the Printing segment’s gross margin slipped to 22 % amid soft demand for consumables. Sector-wide, PC shipments are sensitive to corporate IT-capex cycles and the ongoing shift to hybrid work, while the printing market is being reshaped by cost-pressured enterprises adopting managed print services. HP’s 3D-printing business is growing at a double-digit CAGR, driven by increased adoption in aerospace and automotive prototyping.
For a deeper quantitative view of HP’s valuation and risk profile, you may find the ValueRay platform’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (2.53b TTM) > 0 and > 6% of Revenue (6% = 3.32b TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -1.21pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -12.31% (prev -14.80%; Δ 2.49pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 3.70b > Net Income 2.53b (YES >=105%, WARN >=100%) |
| Net Debt (7.19b) to EBITDA (4.14b) ratio: 1.74 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (948.0m) change vs 12m ago -4.15% (target <= -2.0% for YES) |
| Gross Margin 20.60% (prev 22.07%; Δ -1.46pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 135.4% (prev 134.2%; Δ 1.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.81 (EBITDA TTM 4.14b / Interest Expense TTM 555.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.76
| (A) -0.16 = (Total Current Assets 22.45b - Total Current Liabilities 29.26b) / Total Assets 41.77b |
| (B) -0.05 = Retained Earnings (Balance) -2.03b / Total Assets 41.77b |
| (C) 0.08 = EBIT TTM 3.22b / Avg Total Assets 40.84b |
| (D) -0.06 = Book Value of Equity -2.48b / Total Liabilities 42.12b |
| Total Rating: -0.76 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 56.22
| 1. Piotroski 4.0pt |
| 2. FCF Yield 9.68% |
| 3. FCF Margin 5.06% |
| 4. Debt/Equity -31.45 |
| 5. Debt/Ebitda 1.74 |
| 6. ROIC - WACC (= 26.75)% |
| 7. RoE -281.4% |
| 8. Rev. Trend -52.94% |
| 9. EPS Trend -58.55% |
What is the price of HPQ shares?
Over the past week, the price has changed by -0.13%, over one month by -4.99%, over three months by -13.82% and over the past year by -26.71%.
Is HPQ a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 12
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the HPQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.9 | 13% |
| Analysts Target Price | 25.9 | 13% |
| ValueRay Target Price | 23.6 | 2.8% |
HPQ Fundamental Data Overview December 30, 2025
P/E Trailing = 8.7774
P/E Forward = 7.4184
P/S = 0.3932
P/EG = 1.5786
Beta = 1.231
Revenue TTM = 55.30b USD
EBIT TTM = 3.22b USD
EBITDA TTM = 4.14b USD
Long Term Debt = 8.82b USD (from longTermDebt, last quarter)
Short Term Debt = 1.25b USD (from shortTermDebt, last quarter)
Debt = 10.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.19b USD (from netDebt column, last quarter)
Enterprise Value = 28.92b USD (21.74b + Debt 10.88b - CCE 3.71b)
Interest Coverage Ratio = 5.81 (Ebit TTM 3.22b / Interest Expense TTM 555.0m)
FCF Yield = 9.68% (FCF TTM 2.80b / Enterprise Value 28.92b)
FCF Margin = 5.06% (FCF TTM 2.80b / Revenue TTM 55.30b)
Net Margin = 4.57% (Net Income TTM 2.53b / Revenue TTM 55.30b)
Gross Margin = 20.60% ((Revenue TTM 55.30b - Cost of Revenue TTM 43.90b) / Revenue TTM)
Gross Margin QoQ = 20.23% (prev 20.46%)
Tobins Q-Ratio = 0.69 (Enterprise Value 28.92b / Total Assets 41.77b)
Interest Expense / Debt = 1.15% (Interest Expense 125.0m / Debt 10.88b)
Taxrate = 4.68% (39.0m / 834.0m)
NOPAT = 3.07b (EBIT 3.22b * (1 - 4.68%))
Current Ratio = 0.77 (Total Current Assets 22.45b / Total Current Liabilities 29.26b)
Debt / Equity = -31.45 (negative equity) (Debt 10.88b / totalStockholderEquity, last quarter -346.0m)
Debt / EBITDA = 1.74 (Net Debt 7.19b / EBITDA 4.14b)
Debt / FCF = 2.57 (Net Debt 7.19b / FCF TTM 2.80b)
Total Stockholder Equity = -898.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.05% (Net Income 2.53b / Total Assets 41.77b)
RoE = -281.4% (negative equity) (Net Income TTM 2.53b / Total Stockholder Equity -898.8m)
RoCE = 40.68% (EBIT 3.22b / Capital Employed (Equity -898.8m + L.T.Debt 8.82b))
RoIC = 34.04% (NOPAT 3.07b / Invested Capital 9.03b)
WACC = 7.29% (E(21.74b)/V(32.62b) * Re(10.39%) + D(10.88b)/V(32.62b) * Rd(1.15%) * (1-Tc(0.05)))
Discount Rate = 10.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.83%
[DCF Debug] Terminal Value 68.08% ; FCFE base≈2.94b ; Y1≈2.64b ; Y5≈2.26b
Fair Price DCF = 30.77 (DCF Value 28.25b / Shares Outstanding 918.0m; 5y FCF grow -12.61% → 3.0% )
EPS Correlation: -58.55 | EPS CAGR: -4.38% | SUE: 0.30 | # QB: 0
Revenue Correlation: -52.94 | Revenue CAGR: -3.95% | SUE: 0.06 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.77 | Chg30d=-0.012 | Revisions Net=-5 | Analysts=12
EPS current Year (2026-10-31): EPS=3.12 | Chg30d=-0.251 | Revisions Net=-14 | Growth EPS=+0.0% | Growth Revenue=+1.8%
EPS next Year (2027-10-31): EPS=3.24 | Chg30d=-0.325 | Revisions Net=-10 | Growth EPS=+3.9% | Growth Revenue=+1.4%
Additional Sources for HPQ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle